RE:Growth + this acquisition should bring our EBITDAThe market does not have confidence in management's estimates of future charges on the LSTKs.
Gabriel, I assume your view contradicts the market - are you buying here? I picked up a few shares but I am not diving in...I would like to see management's commentary in the Q2 release, on (1) their responses to questions on the LSTK costs ; and (2) development of the backlog. Backlog development I also want to see where margins are settling. If ARE is truly booking collaborative projects, I assume we should see margin improvement on non-LSTK work.